Evidence map›Paper›PMID 26090412›Full record

ArticleBioMed research international2015

A Novel Method for the Synthesis of (99m)Tc-Ofloxacin Kits Using D-Penicillamine as Coligand and Their Application as Infection Imaging Agent.

Muhammad Abdul Qadir, Shabnam Shahzad, Rashid Rasheed, Mahmood Ahmed, Shahzad Anwar, Syeda Kiran Shahzadi

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Muhammad Abdul QadirInstitute of Chemistry, University of the Punjab, Lahore 54590, Pakistan.
Shabnam ShahzadInstitute of Chemistry, University of the Punjab, Lahore 54590, Pakistan.ORCID 0000-0002-1786-5559
Rashid RasheedGujranwala Institute of Nuclear Medicine and Radiotherapy, Gujranwala, Pakistan.
Mahmood AhmedInstitute of Chemistry, University of the Punjab, Lahore 54590, Pakistan.
Shahzad AnwarInstitute of Chemistry, University of the Punjab, Lahore 54590, Pakistan.
Syeda Kiran ShahzadiInstitute of Chemistry, University of the Punjab, Lahore 54590, Pakistan.
University of the Punjab · PKGIFT University · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The employment of radiopharmaceuticals is increasing nowadays for infection imaging and early execution of patients having infectious or inflammatory complaints. The main aim of this study was to discover a novel method for the labeling of ofloxacin with (99m)Tc, optimization of labelling conditions to get higher percent yield, to assess kits radiochemical purity, in vitro stability, partition coefficient, protein binding, and intracellular accumulation in Pseudomonas aeruginosa, Salmonella typhi, and Escherichia coli in infected rabbits. Maximum labeling efficiency was achieved when 1.5 mg ofloxacin was labeled with 10-20 mCi sodium pertechnetate in the presence of 3 mg D-penicillamine, 75 μg SnCl₂. In vitro binding and biodistribution in Pseudomonas aeruginosa, Salmonella typhi, and Escherichia coli showed good results. This new complex is efficient for the imaging of infections caused by Gram-positive and Gram-negative bacteria.

Indexed as

AnimalsEscherichia coliEscherichia coli InfectionsHumansIsotope LabelingOfloxacinPseudomonas aeruginosaRabbitsRadiopharmaceuticalsSalmonella typhiTechnetiumTissue DistributionOfloxacinRadiopharmaceuticalsTechnetium

Identifiers

PMID26090412
PMCPMC4452244
OpenAlexW1559452290

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.